ScholarLens Back to search
2007•Journal of Zhengzhou UniversityRequires access

Determination of serum IL-18 level in patients with acute coronary syndrome

Shuguang Zhang

Open publisher page 0 citations

Abstract

Aim: To measure the levels of interleukin-18(IL-18) in the serum of patients with acute coronary syndrome (ACS) and explore its relation with ACS. Methods:The serum concentrations of IL-18 were measured in 31 patients with ACS including 12 patients with acute myocardial infarction (AMI group) and 19 patients with unstable angina pectoris(UAP group)by enzyme-linked immunosorbent assay (ELISA). Fifteen patients with stable angina pectoris (SAP group) and 16 controls without coronary diseases were used as control. Results: Serum IL-18 levels in AMI and UAP groups were significantly higher than those in SAP and control group (P0.01). Serum IL-18 levels in SAP group were significantly higher than those in control group(P0.01).Conclusion: Level of serum IL-18 can reflect the stable status of coronary atherosclerosis plaque. IL-18 can be a serum marker to predict the occurrence of ACS.

About this research paper

What this paper is about

Aim: To measure the levels of interleukin-18(IL-18) in the serum of patients with acute coronary syndrome (ACS) and explore its relation with ACS. Methods:The serum concentrations of IL-18 were measured in 31 patients with ACS including 12 patients with acute myocardial infarction (AMI group) and 19 patients with unstable angina pectoris(UAP group)by enzyme-linked immunosorbent assay (ELISA). Fifteen patients with stable angina pectoris (SAP group) and 16 controls without coronary diseases were used as control. Results: Serum IL-18 levels in AMI and UAP groups were significantly higher than those in SAP and control group (P0.01). Serum IL-18 levels in SAP group were significantly higher than those in control group(P0.01).Conclusion: Level of serum IL-18 can reflect the stable status of coronary atherosclerosis plaque. IL-18 can be a serum marker to predict the occurrence of ACS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim: To measure the levels of interleukin-18(IL-18) in the serum of patients with acute coronary syndrome (ACS) and explore its relation with ACS. Methods:The serum concentrations of IL-18 were measured in 31 patients with ACS including 12 patients with acute myocardial infarction (AMI group) and 19 patients with unstable angina pectoris(UAP group)by enzyme-linked immunosorbent assay (ELISA). Fifteen patients with stable angina pectoris (SAP group) and 16 controls without coronary diseases were used as control. Results: Serum IL-18 levels in AMI and UAP groups were significantly higher than those in SAP and control group (P0.01). Serum IL-18 levels in SAP group were significantly higher than those in control group(P0.01).Conclusion: Level of serum IL-18 can reflect the stable status of coronary atherosclerosis plaque. IL-18 can be a serum marker to predict the occurrence of ACS.

Key concepts: Acute coronary syndrome, Unstable angina, Medicine, Myocardial infarction, Internal medicine, Stable angina, Cardiology, Interleukin

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Determination of serum IL-18 level in patients with acute coronary syndrome — Research Paper | ScholarLens